High Remission Rate with Infliximab and Plant-Based Diet as First-Line (IPF) Therapy for Severe Ulcerative Colitis: Single-Group Trial

INTRODUCTION: About one-third of patients with severe ulcerative colitis (UC) do not respond to corticosteroid therapy and receive rescue therapy with infliximab or cyclosporine. Up to 20% of such patients fail to respond to rescue therapy and undergo colectomy. OBJECTIVE: We investigated the outcom...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Perm J
Hlavní autoři: Chiba, Mitsuro, Tsuji, Tsuyotoshi, Nakane, Kunio, Tsuda, Satoko, Ishii, Hajime, Ohno, Hideo, Obara, Yu, Komatsu, Masafumi, Tozawa, Haruhiko
Médium: Artigo
Jazyk:Inglês
Vydáno: The Permanente Press 2020
Témata:
Original Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7931990/
https://ncbi.nlm.nih.gov/pubmed/33482946
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7812/TPP/19.166
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky